1 Contrary to established metabolic pattern, a recent investigation of NNK metabolism produced in rat urine higher levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) 
Introduction
The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is considered to play a major role in the induction of lung cancer in cigarette smokers., Independent of route of administration, NNK is highly carcinogenic to the rodent lung, inducing adenocarcinoma and squamous cell carcinoma in rats, hamsters or mice. In addition, tumours of the nasal mucosa, liver and exocrine pancreas have been observed in rats treated with NNK. 4-(Methylnitrosamino)-l-(3-pyridyl)-1-butanol (NNAL), a major metabolite of NNK induces tumours in the lung of rats and mice and is an especially potent carcinogen for the exocrine pancreas in rats.1 NNK and its reduction product, NNAL are procarcinogens requiring metabolic activation before they can (A,B) , the test (C,D) had a peak with retention times corresponding respectively to reference NNK and NNAL. The identity of the regenerated [5- Generally, alkaline pH was most favourable for the regeneration of NNK, while acidic pH was the least favoured. The effect of pH appears to be least dramatic on the regeneration of NNK by Klebsiella pneumoniae than in any other species found to possess reductive capacity on NNK-N-oxide (Table   1 ). 
